Podcast CME Course Information

Exam: Exam 435: SUDEP in the North American SUDEP Registry: The full spectrum of epilepsies

Issue: July 16, 2019

Learning Objectives

SUDEP in the North American SUDEP Registry: The full spectrum of epilepsies

Upon completion of this podcast, participants will be able to identify clinical features associated with SUDEP risk, such as young adult age, antiseizure medication nonadherence, and frequent generalized tonic-clonic seizures. They will also understand that a sizeable minority of SUDEP occurred in patients thought to be treatment responsive or to have benign epilepsies.

Recommended Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Core Competencies

  • Patient Care
  • Medical Knowledge

Disclosures

Program Accreditations Subcommittee (PAS) is responsible for reviewing and evaluating all CME programs. Joseph F. Kass, MD, JD, FAAN, has received personal compensation for activities as an expert witness in litigation and in an editorial capacity for the American Academy of Neurology. Barney J. Stern, MD, FAAN, has received personal compensation for book chapter contributions. The other members of the committee (Samir Belagaje, MD; J. Clay Goodman, MD, FAAN; Omotola A. Hope, MD; Shannon M. Kilgore, MD, FAAN) and AAN staff (Kristine Mitchell) report no disclosures. Robert A. Gross, MD, PhD, FAAN, has received funding for travel and/or speaker honoraria from the American Academy of Neurology; receives a stipend as Editor-in-Chief of Neurology; has received consultant fees from GlaxoSmithKline and Harris Interactive; has served on speakers' bureaus for Abbott, UCB, and GlaxoSmithKline; has conducted clinical trials over the past 5 years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus, but has ceased participation in industry-sponsored clinical trials and speakers' bureaus since his appointment as Neurology EIC in 2010; and has received research support from the Department of the Army, UCBPharma, and University of Rochester Medical Center/NIH. Dr. Stacey Clardy serves as Podcast Editor for Neurology® and has received research support forWestern Institute for Biomedical Research (WIBR). Dr. Jeff Ratliff serves as Podcast Deputy Editor for Neurology andreceived a speaker honorarium from Haverford College. AAN staff members editing the test (P Baskin, L Kleffman, K Aman Ramm) have no disclosures. The CME Journal Editors who have reviewed the exam are James WM Owens Jr., MD PhD, who receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology and Adam Kelly, MD, who has served as Guest Editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

Dr. Orrin Devinsky has received publishing royalties from Oxford University Press and Demos Press; has acted as a consultant for GW Pharmaceuticals, Cavion, and The Center for Discovery; has served as scientific advisory board member for and/or has equity interest with Tevard, Egg Rock, Engage, Empatica, Rettco, Receptor Life Sciences, and Tilray; has served as principal investigator for a study funded by NINDS, NIMH, Dept. of Defense, CDC; has received commercial research support from GW Pharmaceuticals, Novartis, Marinus, PTC Pharmaceuticals, Ovid Pharmaceuticals, Engage, and Therapeutics Epilepsy Foundation; has received governmental research support from the National Institutes of Health; and holds stock, stock options, or receives Board of Director compensation from Rettco, Tevard, Engage, Pairnomix, Tilray, Options Receptor Life Sciences, Egg Rock, and Empatica. Dr. Ted Burns served as the Section Editor and creator of the Neurology Podcast; has served on the scientific advisory boards for Argenx and Momenta; has received funding for travel or speaker honoraria from Argenx and Alexion; and has received support for consulting activities from UCB Pharma, CSL Behring, Momenta, and Argenx. Dr. Gil Wolfe has served on the scientific advisory boards for Grifols, Takeda, and Orphazyme; has received travel funding or speaker honoraria from Grifols and Alexion; has served as a consultant for Grifols, Takeda, and CSL Behring; has served on speaker’s bureaus for Grifols, Takeda, and CSL Behring; has received commercial research support from Ra Pharma, Immunovant, Argenx, and CSL Behring; and has received governmental research support from the Patient-Centered Outcomes Research Institute.

The other participants report no disclosures.

CME Expiration

CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.

Accreditation

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit™

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Copyright

The American Academy of Neurology holds copyright for all materials in this exam.

Confidentiality

Any information regarding the identity of individuals taking the exam or their exam scores will be kept confidential.

Hardware and Software Requirements

A computer with a web browser such as Internet Explorer, Firefox, Safari, or Google Chrome is required.

Start this exam

For More Information

Patty Baskin

Executive Editor, Neurology®
pbaskin@aan.com
(612) 928-6021